Evidence map›Paper›PMID 35226515›Full record

ArticleInternational journal of immunopathology and pharmacology

Changes in immune profile affect disease progression in hepatocellular carcinoma.

Farshid Fathi, Reza F Saidi, Hamid Reza Banafshe, Mohsen Arbabi, Majid Lotfinia, Hossein Motedayyen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of immunopathology and pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. The Role of CD4Cells · 2026
    Review
  2. Article
  3. Review
  4. Identifying the Crucial Biomarker of MASH-Related HCC.Combinatorial chemistry & high throughput screening · 2025
    Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Farshid FathiDepartment of Immunology, School of Medicine, 48455Isfahan University of Medical Sciences, Isfahan, Iran.
Reza F SaidiDivision of Transplant Services, Department of Surgery, 12302SUNY Upstate Medical University Syracuse, Syracuse, NY, USA.
Hamid Reza BanafshePhysiology Research Center, 48462Kashan University of Medical Sciences, Kashan, Iran.
Mohsen ArbabiDepartment of Medical Parasitology, 48462Kashan University of Medical Sciences, Kashan, Iran.
Majid LotfiniaPhysiology Research Center, 48462Kashan University of Medical Sciences, Kashan, Iran.
Hossein MotedayyenAutoimmune Diseases Research Center, 48462Kashan University of Medical Sciences, Kashan, Iran.
Kashan University of Medical Sciences · IRIsfahan University of Medical Sciences · IRSUNY Upstate Medical University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsDisease ProgressionHumansLeukocytes, MononuclearTh17 CellsTh1 CellsTh2 CellsT-Lymphocytes, Regulatorycellular immunityhepatocellular carcinomaimmune systemT helper cells

Identifiers

PMID35226515
PMCPMC8891922
OpenAlexW4214636439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.